Therapeutic Nutrition With Technology in Primary Care
Supporting and Enabling Physicians to Deliver Personalized Therapeutic Nutrition Using an Online Technology Platform
1 other identifier
observational
100
1 country
1
Brief Summary
Low-carbohydrate diets (less than approximately 130 grams per day) are emerging as an efficacious treatment option with several studies supporting weight loss and remission of type 2 diabetes. Many physicians are now implementing this strategy but the time it takes to educate patients on nutrition is a barrier. The research team is working with physicians to develop a solution whereby the nutrition education and intervention is delivered via mobile/online technology (i.e., an app). This study will test whether it is feasible and efficacious for physicians to recommend this app to their patients with obesity and type 2 diabetes to help them lose weight and improve their condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2020
CompletedFirst Submitted
Initial submission to the registry
October 8, 2020
CompletedFirst Posted
Study publicly available on registry
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedNovember 5, 2020
October 1, 2020
1 year
October 8, 2020
October 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
The percentage of eligible patients who receive prescriptions to access the online TCR program
Assessed through the number of voucher cards handed-out over physician documentation of eligible patient visits over the study period.
through study completion, an average of 9 months
Secondary Outcomes (6)
Present descriptive characteristics of patients who get prescriptions to access the online TCR program
through study completion, an average of 9 months
The percentage of patients who receive a prescription for TCR program that sign up and start
through study completion, an average of 9 months
Program drop-out as assessed by the number of patients who sign up for and start the TCR program and the number of patients who complete the full program.
Pre-program (month 0) to post-program (6 months)
Program impact assessed through changes in weight from pre-program to post-program.
Pre-program (month 0) to post-program (6 months)
Program impact assessed through change in HbA1c from pre-program to post-program.
Pre-program (month 0) to post-program (6 months)
- +1 more secondary outcomes
Other Outcomes (7)
Qualitative patient feedback on program acceptability
Post-program (6 months)
Qualitative patient feedback on program practicality
Post-program (6 months)
Qualitative patient feedback on program satisfaction
Post-program (6 months)
- +4 more other outcomes
Study Arms (1)
Digital therapeutic carbohydrate restriction (TCR) program
The intervention involves 12 weeks of online/app-based behaviour change coaching. Each week the participant focuses on a different aspect of healthy eating habits designed to cut sugar and refined carbohydrates while encouraging and providing resources for lower-carbohydrate food options. Education is done through short videos and information sheets. Participants set goals and complete worksheets/tasks based on their individual goals.
Interventions
A 12-week, personalized, online program to teach and coach patients about therapeutic carbohydrate restriction as for obesity and/or T2D (or risk of T2D). The program is intended to enhance the usual clinical care provided for patients.
Eligibility Criteria
Individuals with obesity, at risk for type 2 diabetes or diagnosed with type 2 diabetes interested in therapeutic carbohydrate restriction for management of their condition.
You may qualify if:
- Overweight or obese (BMI \>25 kg/m2)
- At risk for T2D as deemed by physician
- Diagnosed with T2D
- Able to read and speak English (in order to communicate with the technology platform/app
- Over the age of 18
You may not qualify if:
- Unable to read or speak English (due to the app being provided in English)
- Unable to access a computer or mobile phone that has access to the internet.
- Currently compliant with a very low carbohydrate ketogenic diet or very low calorie commercial weight loss program
- Planning to change doctors in the next 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia Okanagan
Kelowna, British Columbia, V1V 3G1, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathon Little, PhD
The University of British Columbia, Okanagan Campus
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 8, 2020
First Posted
November 5, 2020
Study Start
September 15, 2020
Primary Completion
September 15, 2021
Study Completion
September 30, 2021
Last Updated
November 5, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share